Brexanolone is under clinical development by Sage Therapeutics and currently in Phase I for Post-Traumatic Stress Disorder (PTSD).
Edible flowers bloom with health benefits
Study analyzes the bioactive compounds, antioxidant activities, and aroma profiles of four edible flowers, contributing to their nutritional and health value understanding.